Pharmaceutical Technology
Pfizer gains another obesity asset with $2bn deal for YaoPharma’s GLP-1RA
📊
AI Sentiment
Positive
7/10
Pfizer Inc. News
Latest updates and market news for PFE
20 news
Dec 4 - Dec 10, 2025
Page 1
PR Newswire
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Strategic Pharma Collaborations Propel RCC Market Growth
📈
AI Sentiment
Highly Positive
8/10
Zacks Small Cap Research
CRDF: Initiating Coverage – Combination Therapy Elicits Superior Response
📈
AI Sentiment
Highly Positive
8/10
The Wall Street Journal
Drugmakers Are Ditching Middlemen to Sell Directly to Patients
📊
AI Sentiment
Positive
6/10
MT Newswires
Pfizer Says Hympavzi Reduced Bleeds by 93% Compared With On-Demand Treatment in Phase-3 Study
➖
AI Sentiment
Neutral
5/10
MT Newswires
Eli Lilly, Pfizer Feature in China's Commercial Insurance Innovative Drug Catalog
➖
AI Sentiment
Neutral
5/10
Business Wire
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
📈
AI Sentiment
Highly Positive
8/10
24/7 Wall St.
Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue
📊
AI Sentiment
Positive
6/10
Simply Wall St.
Can Pfizer’s Recent Recovery Signal a Long Term Value Opportunity in 2025?
📊
AI Sentiment
Positive
7/10
Zacks
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
📈
AI Sentiment
Highly Positive
8/10
Zacks
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Sanofi
📊
AI Sentiment
Positive
6/10
Share this news page